N/A
Completed N=25
Tranexamic Acid and Blood Clots in Knee Surgery
Source: ClinicalTrials.gov NCT02867163 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
May 2019
Primary outcomePrimary: Deep Vein Thrombosis — 2 Participants
Summary
This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Deep Vein Thrombosis |
2 | — |
Eligibility Criteria
Inclusion Criteria
- Adult patients scheduled for total knee arthroplasty at Sandoval Regional Medical Center with an intraoperative dose of tranexamic acid
Exclusion Criteria
- Previous deep vein thrombosis or pulmonary embolism episode
- Known coronary artery disease or peripheral vascular disease
- Previously diagnosed hypercoagulable states (e.g. Leiden factor V, antiphospholipid antibody, protein C or S deficiency)
- Pregnancy
- Creatinine clearance less than 30 ml/min
- Non-fluency in English
Data sourced from ClinicalTrials.gov (NCT02867163). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.